Skip to content
★ Sign in to follow
KT

Kaveh T. Safavi

Neopharm Inc
Total declarations
6
Company
1
▲ Purchases (4 ops.)
€15k
▼ Sales (0 ops.)
—

Latest filing published 24 Aug 2006 for NEOPHARM INC, €3,136.

Insider track record

Disclosed buys
4
Disclosed sells
0
Signal history

No signal scores available.

Closed purchases

Market purchases
4

Not enough history yet: 0 closed purchases, at least 2 are needed.

Purchases by company

Kaveh T. Safavi: trading record in brief

Kaveh T. Safavi appears in our data through filings on Neopharm Inc shares, published by SEC (Form 4). Between 19 June 2006 and 22 August 2006, the trades on record add up to 6 filings.

On the market, this insider has only ever bought: 4 purchases, €15k in total. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 2 share grants.

A typical purchase (the median) is worth €3,910.

The newest entry dates from 24 August 2006: an open-market purchase of €3,136, in Neopharm Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Kaveh T. Safavi

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations6 total
  • ▲
    DirectorExecutivesNeopharm Inc
    4,008 USD0SEC
    800 shares@ US$5.01CommonSEC:0001104659-06-056879:2
    Canonical exit: 20 Nov 2006 (T+90)
  • ▲
    DirectorExecutivesNeopharm Inc
    722 USD0SEC
    143 shares@ US$5.05CommonSEC:0001104659-06-056879:3
    Canonical exit: 20 Nov 2006 (T+90)
  • ▲
    DirectorExecutivesNeopharm Inc
    8,860 USD0SEC
    1,751 shares@ US$5.06CommonSEC:0001104659-06-056879:0
    Canonical exit: 20 Nov 2006 (T+90)
  • ▲
    DirectorExecutivesNeopharm Inc
    5,988 USD0SEC
    1,188 shares@ US$5.04CommonSEC:0001104659-06-056879:1
    Canonical exit: 20 Nov 2006 (T+90)
  • ◆
    DirectorExecutivesNeopharm Inc
    0SEC
    7,849 shares0CommonSEC:0001104659-06-051266:0
  • ◆
    DirectorExecutivesNeopharm Inc
    0SEC
    8,090 shares0CommonSEC:0001104659-06-042953:0

6 of 6 declarations